Commercial Papers

Series 1 Commercial Paper - ₦2B Issuance

Logo Jawa International Limited


Issuer Description Size (Bn) Issue Date Maturity Date Tenor (days) Face Value Discount Rate Status
Logo Jawa International Limited
Series 1 Commercial Paper - ₦2B Issuance 2,000,000 2025-07-21 2026-04-17 270 1,000 23.2 active


Jawa International Limited was established in 1993 as an indigenous pharmaceutical manufacturing company committed to the production and distribution of high-quality, affordable medicines. The company operates across various segments of the pharmaceutical industry, specializing in the manufacturing of liquid orals, antibiotics, ointments, and creams. With its headquarters in Lagos, Nigeria. Jawa registered a N2 Billion Series 1 Commercial Paper of its N10 Billion Commercial Paper Issuance Programme which will mature on April 17, 2026.


CP Title: Series 1 Commercial Paper - ₦2B Issuance
ISIN: NGJAWACP2611
Sector: Manufacturing
Categorization: Debt Instrument
Issue Size: 2,000,000
Discount Rate: 23.2
Face Value: 1000
Tenor: 270
Issue Date: 2025-07-21
Maturity Date: 2026-04-17
Instrument Type: Jawa International Limited ₦2,000,000,000 Series 1 Commercial Paper Issuance
Credit Ratings: DataPro Limited: (short Term Rating: A2, Long Term Rating: BBB+)
Issuing and Placing Agent(s) (IPA): Boston Advisory Limited
Collecting and Paying Agent(s) (CPA): Keystone Bank Limited
Issuing, Placing, Paying and Collecting Agent(s) (IPCA): N/A
Status: active
Lead Sponsor Boston Advisory Limited
Joint Spnsors
Managing Director Chief V. Verghese (MFR)
Director Mrs. Annie Verghese
Director Mr. Jacob Kurian
Director Pharm. Chibuzor Dele Michael – Maduaka
Director Boss Mustapha, NPOM (CFR)
Director Dr. Muda Yusuf
Date PDF Download
Address: Jawa House Compound, Plot 6, Abimbola Street, Isolo, Lagos, Nigeria
Email: customerservice@jawasil.com
Web Address: https://jawasil.com/
Company Hotline: 08085406692, 07058791959